Angel Water vs. Adam’s Water Treatment: Voluntary Dismissal in Water Purification Patent Dispute
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Angel Water, Inc. v. Adam’s Water Treatment, Inc. |
| Case Number | 1:24-cv-04550 |
| Court | Illinois Northern District Court |
| Duration | May 31, 2024 – August 16, 2024 77 days |
| Outcome | Voluntary Dismissal without Prejudice |
| Patents at Issue | |
| Accused Products | Technology underlying Angel Water’s PurAclear® Chlorine Injection System |
Case Overview
The Parties
⚖️ Plaintiff
Illinois-based water treatment company offering residential and commercial water purification services and products, including proprietary systems like PurAclear®.
🛡️ Defendant
Competing water treatment provider also operating within Illinois, with market overlap with Angel Water.
The Patent at Issue
This case centered on U.S. Reissue Patent **RE49,098E** (application number US16/989,388). A reissue patent is significant: it indicates that the original patent was corrected through the USPTO reissue process, potentially broadening or clarifying claims after initial grant. The specific technology relates to Angel Water’s chlorine injection water purification system.
- • US RE49,098E — Water purification technology underlying Angel Water’s PurAclear® Chlorine Injection System.
Developing water purification technology?
Check if your system might infringe this or related patents before launch.
The Verdict & Legal Analysis
Outcome
The case concluded via **voluntary dismissal without prejudice** pursuant to FRCP 41(a)(1)(A)(i). No damages were awarded, and no injunctive relief was granted or denied. Angel Water retains the right to refile the same claims against Adam’s Water Treatment in the future.
Verdict Cause Analysis
The dismissal without prejudice is analytically significant: it suggests the dismissal occurred at the earliest possible stage, before the defendant had formally responded to the complaint with an answer or motion for summary judgment. Possible explanations include an early pre-litigation settlement, a licensing agreement, or a strategic recalibration by the plaintiff after assessing the defendant’s likely defenses. Without disclosed settlement terms, the specific motivation remains uncertain. However, the rapid timeline (77 days) strongly suggests an early business resolution or a deliberate plaintiff-side tactical retreat.
The reissue patent at the center of this dispute — RE49,098E — carries specific doctrinal implications. Under 35 U.S.C. § 252, reissue patents are subject to intervening rights defenses, which can limit damages and injunctive relief against parties who began infringing activities before the reissue was granted. For water treatment companies asserting reissue patents against regional competitors, this intervening rights exposure represents a meaningful litigation risk that competent defense counsel would have raised early.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in the water purification sector. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in this technology space
- See which companies are most active in water treatment IP
- Understand reissue patent enforcement patterns
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
Reissue Patent Risk
Potential for intervening rights defenses
1 Reissue Patent
Focused on chlorine injection systems
Early Resolution
Common in regional IP disputes
✅ Key Takeaways
Voluntary dismissal under FRCP 41(a)(1)(A)(i) preserves plaintiff’s rights but often signals pre-answer resolution or strategic retreat.
Search related procedural rulings →Reissue patents introduce intervening rights complexity (35 U.S.C. §252) that defense counsel should raise at the earliest opportunity.
Explore reissue patent case law →Frequently Asked Questions
The case involved U.S. Reissue Patent RE49,098E (application no. US16/989,388), covering technology related to Angel Water’s PurAclear® Chlorine Injection System.
Plaintiff Angel Water voluntarily dismissed the action without prejudice under FRCP 41(a)(1)(A)(i) after 77 days, before the defendant filed an answer. The specific motivation — settlement, licensing, or strategic recalibration — was not publicly disclosed.
The case signals active IP enforcement in regional water treatment markets and highlights the strategic complexity of asserting reissue patents, including intervening rights exposure under 35 U.S.C. §252.
A reissue patent is granted when an original patent is corrected by the USPTO, often to broaden or clarify claims. It’s significant because it can strengthen a patent holder’s ability to enforce their rights, but it also introduces complexities like ‘intervening rights’ defenses for parties who started infringing before the reissue was granted.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- PACER Case 1:24-cv-04550
- USPTO Patent Full-Text Database — US RE49,098E
- Cornell Legal Information Institute — Federal Rule of Civil Procedure 41
- Cornell Legal Information Institute — 35 U.S.C. § 252 (Intervening Rights)
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.